“…It was characterized as described before [12,14]. The molar absorption coefficient was E~~~ = 5.4 x lo3 M -cm-'.…”
Section: Methodsmentioning
confidence: 99%
“…The molar absorption coefficient was E~~~ = 5.4 x lo3 M -cm-'. The inhibitor was converted to I* according to Jering and Tschesche [15,16] and I*-OMe was prepared by esterification of I* with methanol [14]. Both materials were purified and characterized as described earlier [14].…”
Section: Methodsmentioning
confidence: 99%
“…The inhibitor was converted to I* according to Jering and Tschesche [15,16] and I*-OMe was prepared by esterification of I* with methanol [14]. Both materials were purified and characterized as described earlier [14]. Absorption coefficients = 6.1 x lo3 M-' cm-I for I* and 7 x lo3 M-' cm-' for I*-OMe [14].…”
Section: Methodsmentioning
confidence: 99%
“…Both materials were purified and characterized as described earlier [14]. Absorption coefficients = 6.1 x lo3 M-' cm-I for I* and 7 x lo3 M-' cm-' for I*-OMe [14]. a-Chymotrypsin (3 x crystallized, lot CDS 54C404 from Worthington) was checked for its purity by dodecylsulfate gel electrophoresis.…”
Modified trypsin kallikrein inhibitor (I*), with the reactive‐site peptide bond Lys‐15–Ala‐16 split, reacts with α‐chymotrypsin (E) via an intermediate X to the stable tetrahedral complex C: E + I*⇌ X → C. Formation of X constitutes a fast pre‐equilibrium (equilibrium constant Kx= 7 × 10−5 M. association rate constant kx= 4 × 103 M−1 s−1) to the slow reaction X → C (rate constant kc= 2 × 10−3 s−1), all values at pH 7.5. No intermediate X is observed when α‐chymotrypsin reacts with I*‐OMe in which the carboxyl group of Lys‐15 is esterified by methanol. This observation as well as the different pH dependence of the overall association rate constants in the case of I* and I*‐OMe indicate that formation of X precedes formation of the acyl enzyme in the catalytic pathway. The data are compared to the similar results obtained with β‐trypsin and I* or I*‐OMe.
“…It was characterized as described before [12,14]. The molar absorption coefficient was E~~~ = 5.4 x lo3 M -cm-'.…”
Section: Methodsmentioning
confidence: 99%
“…The molar absorption coefficient was E~~~ = 5.4 x lo3 M -cm-'. The inhibitor was converted to I* according to Jering and Tschesche [15,16] and I*-OMe was prepared by esterification of I* with methanol [14]. Both materials were purified and characterized as described earlier [14].…”
Section: Methodsmentioning
confidence: 99%
“…The inhibitor was converted to I* according to Jering and Tschesche [15,16] and I*-OMe was prepared by esterification of I* with methanol [14]. Both materials were purified and characterized as described earlier [14]. Absorption coefficients = 6.1 x lo3 M-' cm-I for I* and 7 x lo3 M-' cm-' for I*-OMe [14].…”
Section: Methodsmentioning
confidence: 99%
“…Both materials were purified and characterized as described earlier [14]. Absorption coefficients = 6.1 x lo3 M-' cm-I for I* and 7 x lo3 M-' cm-' for I*-OMe [14]. a-Chymotrypsin (3 x crystallized, lot CDS 54C404 from Worthington) was checked for its purity by dodecylsulfate gel electrophoresis.…”
Modified trypsin kallikrein inhibitor (I*), with the reactive‐site peptide bond Lys‐15–Ala‐16 split, reacts with α‐chymotrypsin (E) via an intermediate X to the stable tetrahedral complex C: E + I*⇌ X → C. Formation of X constitutes a fast pre‐equilibrium (equilibrium constant Kx= 7 × 10−5 M. association rate constant kx= 4 × 103 M−1 s−1) to the slow reaction X → C (rate constant kc= 2 × 10−3 s−1), all values at pH 7.5. No intermediate X is observed when α‐chymotrypsin reacts with I*‐OMe in which the carboxyl group of Lys‐15 is esterified by methanol. This observation as well as the different pH dependence of the overall association rate constants in the case of I* and I*‐OMe indicate that formation of X precedes formation of the acyl enzyme in the catalytic pathway. The data are compared to the similar results obtained with β‐trypsin and I* or I*‐OMe.
“…Various structural and functional evidence has been pre~ented that the residues preceding Gly 9 of chicken cystatin or ~he homologous Gly ~ in cystatin C bind in the putative $2 and ~' ;3 subsites of papain and are essential for effective inhibition I 18 -20,22]. These findings suggest a formal analogy of the Gly 9-\la 1° bond of chicken cystatin with the 'scissile bond' in the eactive site of small serine proteinase inhibitors, which is fre-, luently cleaved in the enzyme-inhibitor complex according to he so called 'standard mechanism' [5,23,24]. Structural data do lot support this analogy, however: in the docking model of the )apain-chicken cystatin complex and in the experimental strucure of the stefin B-papain complex, the Gly9-Ala ~° bond is ,patially removed from the catalytic Cys 25 residue of papain md thus seems to be not cleavable [25][26][27].…”
Section: Inhibitor Variants As Substratesmentioning
Durch chemische Eingriffe in das aktive Zentrum eines Enzyms ist es gelungen, Lysin gegen Valin, d. h. gegen eine nicht basische Aminosäure, auszutauschen. Auf enzymatischem Wege ist das nicht möglich. Der native Kunitz‐Inhibitor (1) aus Rinderorganen hemmt Trypsin sehr stark und leukocytäre Elastase kaum; das chemisch modifizierte Produkt (2) ist ein sehr guter Inhibitor für Elastase aus menschlichen Leukocyten. Die Methode ist verallgemeinerungsfähigmagnified image.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.